Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flutamide | 1 | 2012 | 4 | 0.360 |
Why?
|
| Androgen Antagonists | 1 | 2012 | 32 | 0.350 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 61 | 0.350 |
Why?
|
| Bone Resorption | 4 | 2007 | 46 | 0.350 |
Why?
|
| beta Catenin | 1 | 2012 | 100 | 0.340 |
Why?
|
| Keratinocytes | 1 | 2012 | 76 | 0.340 |
Why?
|
| Wound Healing | 1 | 2012 | 193 | 0.320 |
Why?
|
| Thyroid Nodule | 2 | 2020 | 15 | 0.310 |
Why?
|
| Testosterone | 3 | 2013 | 128 | 0.280 |
Why?
|
| Skin | 1 | 2012 | 436 | 0.270 |
Why?
|
| T-Lymphocytes | 4 | 2007 | 1010 | 0.250 |
Why?
|
| Interleukin-7 | 2 | 2002 | 30 | 0.240 |
Why?
|
| Thyroid Gland | 2 | 2020 | 83 | 0.190 |
Why?
|
| Thyroid Neoplasms | 2 | 2020 | 87 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2002 | 435 | 0.160 |
Why?
|
| Cytodiagnosis | 1 | 2020 | 46 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 604 | 0.150 |
Why?
|
| ras Proteins | 1 | 2020 | 76 | 0.150 |
Why?
|
| Muscle, Skeletal | 3 | 2013 | 788 | 0.150 |
Why?
|
| Estrogens | 3 | 2004 | 115 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 3500 | 0.130 |
Why?
|
| B-Lymphocytes | 2 | 2013 | 565 | 0.130 |
Why?
|
| Osteogenesis | 3 | 2015 | 154 | 0.130 |
Why?
|
| Mice | 11 | 2013 | 11173 | 0.120 |
Why?
|
| Joints | 1 | 2015 | 33 | 0.110 |
Why?
|
| Myostatin | 1 | 2015 | 20 | 0.110 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 2013 | 2 | 0.100 |
Why?
|
| Anabolic Agents | 1 | 2013 | 8 | 0.100 |
Why?
|
| Organ Sparing Treatments | 1 | 2013 | 17 | 0.100 |
Why?
|
| Animals | 13 | 2015 | 21459 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 134 | 0.100 |
Why?
|
| Prostate | 1 | 2013 | 124 | 0.090 |
Why?
|
| Muscle Strength | 1 | 2012 | 41 | 0.090 |
Why?
|
| Aging | 2 | 2015 | 775 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 10 | 0.090 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 31 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 98 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 369 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 74 | 0.090 |
Why?
|
| Doxycycline | 1 | 2011 | 47 | 0.090 |
Why?
|
| Mutation | 1 | 2020 | 2670 | 0.090 |
Why?
|
| Amyloid | 1 | 2011 | 74 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 239 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2012 | 190 | 0.080 |
Why?
|
| Amyloidosis | 1 | 2011 | 70 | 0.080 |
Why?
|
| Regeneration | 1 | 2012 | 126 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 222 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2020 | 68 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2007 | 287 | 0.070 |
Why?
|
| Osteoclasts | 3 | 2007 | 53 | 0.070 |
Why?
|
| Cytokines | 1 | 2013 | 964 | 0.070 |
Why?
|
| Sepsis | 1 | 2012 | 302 | 0.070 |
Why?
|
| Osteoprotegerin | 2 | 2007 | 6 | 0.060 |
Why?
|
| RANK Ligand | 2 | 2007 | 23 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2013 | 3162 | 0.060 |
Why?
|
| Osteoporosis | 2 | 2007 | 113 | 0.060 |
Why?
|
| Ovariectomy | 2 | 2003 | 104 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 733 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2004 | 321 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2004 | 576 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 1277 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 754 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 383 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2326 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 181 | 0.050 |
Why?
|
| Male | 8 | 2020 | 31292 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 7 | 0.050 |
Why?
|
| Orchiectomy | 2 | 2013 | 40 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 37 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 64 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 1291 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 145 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2004 | 792 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 151 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2002 | 189 | 0.040 |
Why?
|
| Estradiol | 1 | 2002 | 260 | 0.040 |
Why?
|
| Motor Activity | 2 | 2015 | 346 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 19 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2020 | 17 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 662 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 198 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 417 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2002 | 2189 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2002 | 718 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2020 | 224 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 235 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 316 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1633 | 0.030 |
Why?
|
| Female | 6 | 2020 | 34309 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2015 | 2168 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 429 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 29 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2015 | 25 | 0.030 |
Why?
|
| Tendons | 1 | 2015 | 27 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Extremities | 1 | 2015 | 63 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1580 | 0.030 |
Why?
|
| Muscles | 1 | 2015 | 179 | 0.030 |
Why?
|
| Bone Density | 2 | 2007 | 142 | 0.030 |
Why?
|
| Humans | 6 | 2020 | 65645 | 0.030 |
Why?
|
| Eflornithine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Ornithine Decarboxylase | 1 | 2013 | 5 | 0.030 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cathepsin L | 1 | 2013 | 21 | 0.030 |
Why?
|
| Follistatin | 1 | 2013 | 44 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 15089 | 0.030 |
Why?
|
| Organ Size | 1 | 2013 | 174 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 200 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 83 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 132 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2013 | 80 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 132 | 0.020 |
Why?
|
| Mifepristone | 1 | 2012 | 19 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 28 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 17511 | 0.020 |
Why?
|
| Actomyosin | 1 | 2012 | 21 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 297 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 18439 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 3329 | 0.020 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2012 | 1 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 13 | 0.020 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2012 | 15 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 377 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 48 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2011 | 16 | 0.020 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2011 | 6 | 0.020 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 42 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2011 | 53 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 708 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 202 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 295 | 0.020 |
Why?
|
| Stomach | 1 | 2011 | 87 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.020 |
Why?
|
| Base Sequence | 2 | 2004 | 1331 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 624 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2011 | 94 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 371 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1487 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5656 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 898 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1996 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 6948 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1042 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1592 | 0.020 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1633 | 0.020 |
Why?
|
| CD40 Antigens | 1 | 2007 | 59 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2007 | 159 | 0.020 |
Why?
|
| Inflammation | 1 | 2013 | 1195 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2007 | 204 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 807 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 30 | 0.010 |
Why?
|
| Bone Development | 1 | 2004 | 33 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2003 | 20 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 450 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2002 | 46 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2003 | 180 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2004 | 239 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 301 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 869 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 436 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 542 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 514 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 1041 | 0.010 |
Why?
|